These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3605160)

  • 1. Compassionate use of norfloxacin.
    Heseltine PN; Corrado ML
    Am J Med; 1987 Jun; 82(6B):88-92. PubMed ID: 3605160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.
    Corrado ML; Grad C; Sabbaj J
    Am J Med; 1987 Jun; 82(6B):70-4. PubMed ID: 3300314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection.
    Cox CE; McCabe RE; Grad C
    Am J Med; 1987 Jun; 82(6B):59-64. PubMed ID: 3300312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial.
    Goldstein EJ; Alpert ML; Najem A; Eng RH; Ginsburg BP; Kahn RM; Cherubin CE
    Am J Med; 1987 Jun; 82(6B):65-9. PubMed ID: 3300313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiclinic study of norfloxacin for treatment of urinary tract infections.
    Schaeffer AJ
    Am J Med; 1987 Jun; 82(6B):53-8. PubMed ID: 3300311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of urinary tract infection with norfloxacin. Analysis of cost.
    Ramirez-Ronda C; Colon M; Saavedra S; Sabbaj J; Corrado ML
    Am J Med; 1987 Jun; 82(6B):75-8. PubMed ID: 3300315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin: its potential in clinical practice.
    Lee C; Ronald AR
    Am J Med; 1987 Jun; 82(6B):27-34. PubMed ID: 3300309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Norfloxacin in the treatment of urinary tract infections].
    Joost J
    Wien Klin Wochenschr; 1986 May; 98(11):355-7. PubMed ID: 3524016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.
    Wolfson JS; Hooper DC
    Ann Intern Med; 1988 Feb; 108(2):238-51. PubMed ID: 3277508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
    Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
    Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerance of norfloxacin in treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injury.
    Waites KB; Canupp KC; DeVivo MJ
    Urology; 1991 Dec; 38(6):589-96. PubMed ID: 1746095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfloxacin versus trimethoprim-sulfamethoxazole in the treatment of urinary tract infections.
    Corrado ML; Hesney M; Struble WE; Brown KR; Eng RH; Landes R; Harrison L; Ryan J; Bolding OT
    Eur Urol; 1990; 17 Suppl 1():34-9. PubMed ID: 2191867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral temafloxacin compared to norfloxacin for the treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1991 Dec; 91(6A):129S-133S. PubMed ID: 1662883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norfloxacin: a three-day course for the treatment of urinary tract infection.
    Ganguli LA; Keaney MG; Gould LJ
    Drugs Exp Clin Res; 1985; 11(3):177-9. PubMed ID: 3836125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of norfloxacin and trimethoprim for the treatment of elderly patients with urinary tract infection.
    Ewer TC; Bailey RR; Gilchrist NL; Aitken JM; Sainsbury R
    N Z Med J; 1988 Aug; 101(852):537-9. PubMed ID: 3045717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
    Iravani A
    Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
    Neringer R; Forsgren A; Hansson C; Ode B
    Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.